Read More 5 minute read Pharma Industry News Krystal Biotech stock jumps after FDA expands Vyjuvek label to newborns and at-home use Krystal Biotech stock surged after the FDA expanded Vyjuvek’s label to newborns and caregiver use, boosting adoption potential and investor confidence. byPallavi MadhirajuSeptember 15, 2025